Recruiters pay vulnerable addicts to try experimental treatment to kick heroin
There are believed to be more than 600,000 opioid addicts in the U.S. A scheme that preys on many involves Naltrexone, a drug that curbs cravings. The FDA approved it in some forms, but not as a surgical implant.
Skip to content
